Jordi Sabé
Founding Partner 

Industry Advisor at Advent International, Board Member Cantabria Labs

Previously, Senior Vice President of Corporate Development, member of the Executive Committee, Investment Committee and Strategy Commission of the Board of Directors at Almirall

Prior to the latter, held several positions in investment banking at KPMG and Alta Partners as well at GE

Degree in Business Administration from University of Barcelona/University of California (Berkeley), MBA from IE Business School and executive programmes at Harvard, INSEAD and University of Chicago

Ferdinand Mayer
Founding Partner

Investment Director at Goodgrower, a leading investor in the European healthcare space

Previously worked in investment banking, covering the European healthcare mid-market from London (Nomura and Piper Jaffrey)

Over 20 transactions completed as a principal investor (Goodgrower), and approximately 20 as an adviser (IPOs, M&A, financing rounds during 6 years in investment banking)

Degree in Biotechnology from Imperial College, MBA from IESE Business School

Dr. Christian Mazzi
Operating Partner

Chief Executive Officer at CORCYM, a global medical device company focused on cardiac surgery

Previously was the President of Adlon Therapeutics and Chief Commercial Officer at Mundipharma International

Prior to the latter, was the Healthcare Lead Partner at Bain & Company in the UK

Started his career as a physician and trained in Internal Medicine at the Massachusetts General Hospital

Degree in Biology/Biological Sciences from University of Boston and medicine from University of Sydney; MBA from INSEAD

Dr. Thomas Eichholtz
Operating partner

Head of Global Research and Development at the Chiesi Group

Previously Executive Director External R&D at Mundipharma Research Limited

Prior to joining Mundipharma, was Executive Vice President, Chief Scientific Officer and member of the Executive Committee at Almirall

Prior to the latter, held several R&D senior positions both in Astra Zeneca and Pfizer

Degree in Biology from the Utrecht University  and PhD in Cellular Biochemistry from the Netherlands Cancer Institute

Advisory Partners

Dr. Francesco Granata

Chairman of Circassia Plc and a Board member of Italfarmaco, Prismic Pharmaceuticals and Quanta Ltd.

Senior advisor at Warburg Pincus Int.

Dr Granata was member of the Executive Committee at Biogen Idec, and served as Group Vice President for Schering-Plough Europe and Canada

Previously held senior management positions with Pfizer, Pharmacia and Dompѐ Biotec

Eduardo Sanchiz 

Board Member at Caixabank

Board member at Pierre Fabre

Former CEO of Almirall

Former Executive Director Europe at Eli Lilly

Master in Economics and Business Admistration, Deusto University and MBA IE Business School

© 2019 

All Rights Reserved